Midtrimester Amniotic Fluid Tumor Necrosis Factor‐Alpha Does Not Predict Small‐for‐Gestational‐Age Infants

PROBLEM: To evaluate the independent ability of midtrimester amniotic fluid tumor necrosis factor‐alpha (TNF‐α) in the prediction of small‐for‐gestational‐age (SGA) infants.

[1]  A. Peaceman,et al.  Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. , 1994, American journal of obstetrics and gynecology.

[2]  S. Witkin,et al.  Tumor necrosis factor-alpha in midtrimester amniotic fluid is associated with impaired intrauterine fetal growth. , 1992, American journal of obstetrics and gynecology.

[3]  I. Sargent,et al.  Localization of tumour necrosis factor production in cells at the materno/fetal interface in human pregnancy , 1992, Clinical and experimental immunology.

[4]  L. River,et al.  Comparison of associated high-risk factors and perinatal outcome between symmetric and asymmetric fetal intrauterine growth retardation. , 1991, American journal of obstetrics and gynecology.

[5]  G. Wennergren,et al.  Obstetric Characteristics and Neonatal Performance in a Four-Year Small for Gestational Age Population , 1988, Obstetrics and gynecology.

[6]  B. Graubard,et al.  Birth weight among women of different ethnic groups. , 1986, JAMA.

[7]  G. Visser,et al.  Early Fetal Growth Retardation: Obstetric Background and Recurrence Rate , 1986, Obstetrics and gynecology.

[8]  G. Cutter,et al.  Low birth weight, intrauterine growth retardation, and preterm delivery. , 1985, American Journal of Obstetrics and Gynecology.

[9]  B. Beutler,et al.  Identity of tumour necrosis factor and the macrophage-secreted factor cachectin , 1985, Nature.

[10]  R. Creasy,et al.  Fetal Growth and Perinatal Viability in California , 1982, Obstetrics and gynecology.